Press Releases and Blog
Blog
ICYMI: Economic Experts Sound Alarm On Misguided Legislation Targeting Pharmacy Benefit Companies
Economists Explain Policies Restricting Pharmacy Benefits Will Lead To Higher Costs, Less Competition, And Fewer Choices For Employers In case you missed it, Joe Grogan,
Don’t Be Fooled: Big Pharma Keeps the Vast Majority of the Rx Dollar
A simple fact is often lost in the din of the current drug pricing debate going on in Washington D.C. and around the country: Drug
Disclosure Requirements Could Impact Manufacturer Rebates
New report finds a potential result of disclosure requirements could increase federal government costs by $134 billion over 10 years Congress continues to consider proposals
New PCMA Rx Research Corner Blog Post: Dr. Lawton Robert Burns Sheds Light on the Role of PBMs
“PBMs promote competition in healthcare and help to reduce prices,” said Lawton Robert Burns Hot Off the Presses: University of Pennsylvania Wharton School professor Lawton
New Legislation Aims to Increase Competition in U.S. Biosimilar Market
Pharmacy benefit companies are strong proponents of a highly functioning biosimilar market. Bringing more biosimilars to market, over time, will allow PBMs to more effectively
Eliminating Spread Pricing Would Lead to Higher Costs and Fewer Choices for America’s Employers
What is spread pricing? Spread pricing is a contract option for employers and plan sponsors who want their pharmacy benefit company to carry the risk that pharmacies
Press Releases
PCMA Statement on the Senate Finance Committee Hearing on Prescription Drug Prices in Medicare
(Washington D.C.) – Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s Senate Finance Committee hearing, “Prescription Drug Price Inflation:
PCMA Statement on the Pre-Approval Information Exchange Act
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today issued the following statement on H.R. 7008, the Pre-approval Information Exchange (PIE) Act:
PCMA Applauds Passage of Postal Service Reform Act
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the passage of the Postal Service Reform
Medicare Part D 2023 Proposed Rule Could Increase Costs
New Milliman Analysis Shows Medicare Part D Proposed Rule Could Increase Premiums More than It Saves in Cost Sharing for Majority of Beneficiaries (Washington, D.C.) —
Rite Aid’s PBM Elixir Joins the Pharmaceutical Care Management Association
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today announced that Elixir, Rite Aid’s pharmacy benefit manager (PBM) business, is joining the trade association.
PBMs Committed to Building a More Equitable Health Care System
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on a new report by the U.S. Health and Human
PCMA’s Kristin Bass Testifies on the Value Pharmacy Benefit Companies
Bass Explains Opposition to Legislation, Risk of Drug Companies Lowering Rx Discounts On Wednesday, expert witnesses testifying before the U.S. House Committee on Energy & Commerce
PCMA Policy Forum Highlights Indispensable Value of Savings Secured by Pharmacy Benefit Companies
Speakers Discuss Pharmacy Benefit Company Innovations, Importance of Protecting Cost Saving Role, and Solutions to Improve Affordability
Recognizing the Private Market’s Ability to Meet Evolving Demand
Pharmacy Benefit Companies Innovate to Provide Choice for Clients, Lower Costs for Patients Even as Congress considers more government intervention and “drug pricing” legislation that
ICYMI: Professor Of Health Care Management Explains Critical Role of Pharmacy Benefit Companies
Dr. Lawton Burns Says PBMs are Unfairly Blamed for High Drug Prices, Should Look At Big Drug Companies In case you missed it, Lawton R.
ICYMI: Achieving An Affordable Health Care Future For Patients
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), discusses the root cause of high drug prices
America’s Pharmacy Benefit Companies Secure Billions of Dollars in Savings for Taxpayers
Misguided Policies Undermining Pharmacy Benefits Would Dramatically Increase Federal Spending Pharmacy benefit companies are working every day to secure savings for patients, families, and taxpayers.
Wide Array of Community Leader Voices Oppose Legislation, S. 127, Expanding FTC Power to Pick Winners and Losers
A wide array of voices from across the country are calling on lawmakers to oppose recently reintroduced legislation, the Pharmacy Benefit Manager Transparency Act (S.127),
WATCH NOW: Prescription for Change: Improving Competition to Lower Drug Prices
In a new web video, Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott discusses the critical role and value of pharmacy benefit companies,
Policymakers, Drug Pricing and Economic Experts Highlight Importance of Greater Competition to Lower Drug Prices
Conversation on “Improving Competition to Lower Drug Prices” Emphasizes Need to Stop Abuse of the Patent System Last week, The Hill hosted an event titled, “Prescription for Change:
Legislation Targeting REMS Abuse Adds to Bipartisan Action on Solutions to Boost Competition and Lower Prescription Drug Costs
Lawmakers Reintroduce Bill to Close Loopholes Allowing Big Drug Companies to Block Competition from More Affordable Options The Pharmaceutical Care Management Association, PCMA, applauds Senators